Prelude Capital Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,000
Closed -$806K 1947
2022
Q1
$806K Buy
+15,000
New +$873K 0.02% 670
2021
Q3
Sell
-24,000
Closed -$1.31M 1894
2021
Q2
$1.31M Sell
24,000
-96,000
-80% -$6.06M 0.04% 467
2021
Q1
$7.14M Hold
120,000
0.18% 69
2020
Q4
$5.67M Buy
+120,000
New +$5.05M 0.14% 88
2020
Q1
Sell
-3,000
Closed -$88K 1774
2019
Q4
$88K Buy
+3,000
New +$79.7K ﹤0.01% 1156
2019
Q3
Sell
-39,000
Closed -$733K 1901
2019
Q2
$733K Sell
39,000
-62,000
-61% -$1.18M 0.04% 419
2019
Q1
$1.81M Sell
101,000
-110,000
-52% -$1.84M 0.1% 204
2018
Q4
$2.87M Buy
+211,000
New +$3.02M 0.19% 105

Other funds holding LRCX

Prelude Capital Management's LRCX Position: Q1 2026 in Review

Prelude Capital Management increased its Lam Research (LRCX) stake by 55% in Q1 2026, buying an estimated $829K and bringing the position to 10,423 shares worth $2.23M. The position accounts for 0.17% of the portfolio, ranked #146.

Prelude Capital Management first reported a position in LRCX in Q3 2013 and has held it in 33 quarters since. The position peaked at $6.26M in Q3 2017. 2,632 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Prelude Capital Management held 10,423 shares of Lam Research worth $2.23M as of Q1 2026.
  • Prelude Capital Management bought 3,709 Lam Research shares in Q1 2026, an estimated $829K.
  • Lam Research made up 0.17% of Prelude Capital Management's portfolio in Q1 2026, its #146 holding.
  • Prelude Capital Management first reported a position in Lam Research in Q3 2013 and has held it in 33 quarters since.
  • Prelude Capital Management's Lam Research position peaked at $6.26M in Q3 2017.
  • 2,632 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.